LAG3 was identified as an important therapeutic target in pancreatic cancer, liver, brain, breast cancer and melanoma (Gulhati et al., 2023; Huuhtanen et al., 2023; Ulase et al., 2023; Zou et al., 2023). This evidence concerns the gene LAG3 and familial pancreatic carcinoma.